NCT03333967Unknown不适用
The Real World Study of Apatinib for Gastric Cancer Treatment in Anhui Province
The First Affiliated Hospital of Anhui Medical University1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2017年9月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 入组人数
- 1,000
- 试验地点
- 1
- 主要终点
- Progress free survival
研究概览
简要总结
The investigators conduct the real world study to explore the efficacy and safety of Apatinib in gastric cancer .
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female patients .
- •Confirmed by Pathology or histology of Gastric cancer
- •Patients should be voluntary to the trial and provide with signed informed consent
- •The researchers believe patients can benefit from the study.
排除标准
- •Patients with a known history of allergic reactions and/or hypersensitivity attributed to apatinib or its accessories
- •Pregnant or lactating women
- •Patients with Apatinib contraindications
- •Patients of doctors considered unsuitable for the trial
结局指标
主要结局
Progress free survival
时间窗: 1 year
Progress free survival is defined as the length of time from random assignment to disease progression or to death resulting from any cause other than the progress.
次要结局
- overall survival(3year)
- Objective tumor response rate(1year)
- disease control rate(1year)
- Disease-free survival(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
不适用
The Real World Study of Apatinib for Gastric Cancer Treatment in Henan ProvinceGastric CancerNCT03478943Henan Cancer Hospital1,000
Unknown
不适用
A Real World Study of Apatinib in Treatment of Patients With Gastric CarcinomaGastric CarcinomaNCT03735511Henan Cancer Hospital270
招募中
不适用
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing MethodOrganoidsGastric CancerNCT06100003Funan Liu104
Unknown
2 期
Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal CancerNeoadjuvant TherapyColorectal CancerNCT03377842Sichuan Provincial People's Hospital100
Unknown
2 期
Apatinib as First -Line Treatment for Advanced Esophagus CancerAdvanced Esophagus CancerNCT03542422Affiliated Hospital of North Sichuan Medical College50